| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
Market Maker
|
Awaited |
48,000
|
— | ₹0.17 |
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 900,000 |
100% | ₹3.24 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Market Maker | 48,000 | ₹0.17 |
5.33%
|
| Total | 900,000 | ₹3.24 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 6,000 | ₹216,000 |
| Retail (Max — 13 Lots) | 13 | 39,000 | ₹1,404,000 |
| S-HNI (Min — 14 Lots) | 14 | 42,000 | ₹1,512,000 |
| B-HNI (Min — 68 Lots) | 68 | 204,000 | ₹7,344,000 |
| Particulars | 30-Jun-21 | 31-Mar-21 | 31-Mar-20 |
|---|---|---|---|
| Revenue from Operations | 1.13 | 3.06 | 7.52 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 0.01 | 0.03 | 0.07 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 2.81 | 2.25 | 3.59 |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Fabino Life Sciences Ltd. IPO is subscribed 1.00 times by Jan 05, 2022. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Fabino Life Sciences Ltd. IPO retail category is subscribed 1.00 times as of 05 Jan 2022. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 31 Dec 2021 and closes 05 Jan 2022. Min investment: ₹108,000 (1 lot = 3,000 shares). UPI mandate: 2022-01-05.
The Fabino Life Sciences Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (Bigshare Services Pvt.Ltd.) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 10 Jan 2022. Refunds: on 11 Jan 2022.
The Fabino Life Sciences Ltd. IPO listing date is 13 Jan 2022, Thursday. Listed on: BSE SME. Issue price: ₹36. Estimated listing: ₹36. GMP: NIL.
The Fabino Life Sciences Ltd. IPO closes on 05 Jan 2022, Wednesday. UPI mandate: 2022-01-05. Allotment: 10 Jan 2022. Listing: 13 Jan 2022.